Transcript WISH_WilcoxMamykina

Lena Mamykina, Lauren Wilcox, David Vawdrey
Daniel Stein, Sarah Collins, Stewin Camargo
Matt Fred, George Hripcsak, Steven Feiner
A Living Laboratory for Health IT
Outline

Background

Innovation Cycle

Project Overviews

Insights to Share
2
NewYork-Presbyterian Health Care System (NYP)

NYP
 2 Academic Medical Centers
(Columbia & Cornell)
 Multiple inpatient and outpatient sites
 2,242 patient beds
 111,764 discharges annually

Ranked among America’s Best
Hospitals by U.S.News
3
Health IT - HCI Engagement
Formative
studies
Research
and
Development
User-centered
Deployment
Evaluation
design Commercial
Prototype
Product
Evaluation studies
Fixes Features
4
Living Laboratory
Research
Research
and Evaluation
Deployment
Evaluation
Development
Development
Deployment
Academic Medical Center
5
Computerized Unified Patient
Information Device (CUPID)
Including cardiology patients and their loved
ones as part of the inpatient care team

Design and development of bedside
technology facilitating patient views into the
EHR, medications, care team info
6
Computerized Unified Patient Information
Device (CUPID)
7
Medication Reconciliation
Achieving effective medication reconciliation
across care settings
8
Medication Reconciliation

We implemented an electronic process using our commercial
EHR and improved documentation of medication
reconciliation at hospital admission
(forthcoming paper)
9
Next-Generation Electronic
Documentation
Improving electronic documentation tools
and assessing their use

SmartPaste
10
Next-Generation Electronic
Documentation
Improving electronic documentation tools
and assessing their use

activeNotes
11
Task management
Supporting collaborative management of tasks
and interdisciplinary patient care goals
12
Push notification
13
Design Challenges/Opportunities

Ongoing access to domain experts

Balancing innovation and familiarity

Technological ecosystem
14
Implementation Challenges

Integration with outdates or proprietary
technology

Conforming to standards

Protective overall ecosystem
15
Evaluation Challenges/Opportunities

Possibility to study long-term adoption

Complex study designs

Evaluation metrics
16
THANK YOU!
17